 |
 |

Cyclophosphamide-Induced UrticariaOccurrence in a Patient With No Cross-Sensitivity to Chlorambucil
Allan N. Krutchik, MD;
Aman U. Buzdar, MD;
Charles K. Tashima, MD
Arch Intern Med. 1978;138(11):1725-1726.
Abstract
A patient receiving adjuvant chemoimmunotherapy for breast carcinoma developed urticaria secondary to cyclophosphamide, one of the drugs of the chemotherapy regimen. Chlorambucil, another alkylating agent, was substituted with no cross-sensitivity noted.
(Arch Intern Med 138:1725-1726, 1978)
Author Affiliations
From the Medical Breast Service, Department of Medicine, University of Texas System Cancer Center, M. D. Anderson Hospital and Tumor Institute, Houston.
Footnotes
Accepted for publication June 7, 1978.
Reprint requests to Department of Medicine, M. D. Anderson Hospital and Tumor Institute, 6723 Bertner Ave, Houston, TX 77030 (Dr Buzdar).
CiteULike Connotea Delicious Digg Facebook Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Cyclophosphamide type I hypersensitivity in systemic lupus erythematosus
Thong et al.
Lupus 2002;11:127-129.
ABSTRACT
Hypersensitivity Reactions to Cancer Chemotherapeutic Agents
WEISS and BRUNO
ANN INTERN MED 1981;94:66-72.
ABSTRACT
|